Biomolecule separation is generally required in workflows in agricultural, biotechnology, environmental, food and pharmaceutical applications. The type of separation used is crucial for successful product recovery or purification, and reliable delivery of protein composition is important in downstream processing. Bioprocess chromatography is frequently used for downstream processing of cells, including the purification of peptides, oligonucleotides, […]

Company Announcements ALPCO announced in July a strategic account sales and distribution agreement with Cisbio US. In August, Meridian Bioscience named Catherine A. Sazdanoff, president of Sazdanoff Consulting, and John C. McIlwraith, managing director of Allos Ventures, to its Board. Eurogentec appointed MoBiTec as a distributor of its AnaSpec products, qPCR kits, oligonucleotides and other […]

Company Announcements Under a mutual distribution agreement signed in July, Rigaku Reagents will promote and sell MiTeGen’s crystallization, crystal harvesting, data collection and other product lines worldwide, and MiTeGen will promote and sell Rigaku’s Wizard product lines of matrix screens and other products in the US. In August, Oxford Instruments appointed Hillsborough General Trading as […]

Company Announcements Advaita Bioinformatics entered into an exclusive distribution partnership with Riken Genesis in April for Japan for its iPathway Guide platform. Core Informatics announced in July the closing of a $17.5 million Series B funding, led by Oak HC/FT. In July, RURO partnered with Integrated Systems Engineering to provide its LIMS to biobanks, with […]

For the third straight year, Canada’s gross domestic expenditure on R&D (GERD) in 2015 is expected to decline, falling 0.7% to CAD 31.6 billion ($23.8 billion). This drop is predicted for spending in all performing sectors except higher education and the federal government, which are anticipated to experience 1.0% and 4.0% increases to CAD 13.0 […]

A survey by Farmaindustria found that Spain’s pharmaceutical industry spent €950 million ($1.06 billion) on R&D in 2014. This rise in investment followed three years of declines related to the economic crisis. Intramural research accounted for €568 million, or 59% of expenditures, while the remaining investment of €382 million was put toward research contracts with […]

A survey of 191 US universities, hospitals and research institutions, and one third-party technology investment firm showed gains in academic licensing and startup activity in 2014. These gains were despite a 5% drop in federal research funding to $37.9 billion. Respondents’ research expenditures overall fell 3.6% to $62.8 billion, but spending funded by industry rose […]

In 2016, the top 20 pharmaceutical companies’ sales of products gained through mergers and acquisitions are expected to match those of products developed within the companies. By net present value, only 36% of phase III drugs were internally developed, whereas 31%, 31% and 2% of them were obtained through acquisitions of companies, in-licensing and acquisitions […]

Based on the categorization of more than 35 million research papers into major disciplines by their journals of publication, and the proportion of references they cited from within or outside the same discipline, interdisciplinary research has been increasing since the mid-1980s. Three years following publication, the citation rates of articles decreased with the degree of […]